ONTOLOGY REPORT - ANNOTATIONS
| Term: | imatinib |
|
| Accession: | CHEBI:45783
|
browse the term
|
| Definition: | A N-methylpiperazine that has formula C29H31N7O. |
| Synonyms: | related_synonym: | 4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE; 4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide; C29H31N7O; CN1CCN(CC1)Cc1ccc(cc1)C(=O)Nc1ccc(C)c(Nc2nccc(n2)-c2cccnc2)c1; InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34); InChIKey=KTUFNOKKBVMGRW-UHFFFAOYSA-N; STI 571; alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-toluidide |
| | alt_id: | CHEBI:305376; CHEBI:38918; CHEBI:45781 |
| | xref_casrn: | 152459-95-5 |
| | xref: | Beilstein:7671333 "Beilstein Registry Number"; ChEMBL:188797 "ChEMBL COMPOUND"; ChEMBL:305376 "ChEMBL COMPOUND"; ChemIDplus:152459-95-5 "CAS Registry Number"; CiteXplore:17457302 "PubMed citation"; CiteXplore:18407734 "PubMed citation"; DrugBank:DB00619 "DrugBank" |
| | xref_mesh: | MESH:C097613 |
| | xref: | PDBeChem:STI "PDBeChem"; Patent:EP564409 "Patent"; Patent:US5521184 "Patent"; Wikipedia:Imatinib "Wikipedia" |
|
|
imatinib
|
| G |
Abcb11 |
ATP-binding cassette, subfamily B (MDR/TAP), member 11 |
|
decreases activity |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
increases expression |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
multiple interactions |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcc10 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 10 |
|
multiple interactions |
ISO |
9 |
10,219,822 |
10,239,734 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
increases expression |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
multiple interactions |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
multiple interactions |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abcg2 |
ATP-binding cassette, subfamily G (WHITE), member 2 |
|
increases export |
ISO |
4 |
87,502,584 |
87,560,017 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
multiple interactions |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
increases response to substance |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
decreases response to substance |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
multiple interactions |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
multiple interactions |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
decreases activity |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
decreases phosphorylation |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
multiple interactions |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
decreases phosphorylation |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
decreases expression |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
multiple interactions |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
decreases phosphorylation |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Abl1 |
c-abl oncogene 1, non-receptor tyrosine kinase |
|
multiple interactions |
ISO |
3 |
10,804,594 |
10,907,162 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases expression |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases expression |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
decreases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
multiple interactions |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldh2 |
aldehyde dehydrogenase 2 family (mitochondrial) |
|
decreases expression |
ISO |
12 |
36,081,778 |
36,116,445 |
RGD:6480464 |
CTD |
| G |
Aldoc |
aldolase C, fructose-bisphosphate |
|
multiple interactions |
ISO |
10 |
64,308,826 |
64,312,415 |
RGD:6480464 |
CTD |
| G |
Aldoc |
aldolase C, fructose-bisphosphate |
|
decreases expression |
ISO |
10 |
64,308,826 |
64,312,415 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
increases expression |
EXP |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
multiple interactions |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
multiple interactions |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bcl2l11 |
BCL2-like 11 (apoptosis facilitator) |
|
increases response to substance |
ISO |
3 |
115,692,323 |
115,722,701 |
RGD:6480464 |
CTD |
| G |
Bcr |
breakpoint cluster region |
|
multiple interactions |
ISO |
20 |
13,972,773 |
14,097,816 |
RGD:6480464 |
CTD |
| G |
Bcr |
breakpoint cluster region |
|
multiple interactions |
ISO |
20 |
13,972,773 |
14,097,816 |
RGD:6480464 |
CTD |
| G |
Bcr |
breakpoint cluster region |
|
decreases activity |
ISO |
20 |
13,972,773 |
14,097,816 |
RGD:6480464 |
CTD |
| G |
Bcr |
breakpoint cluster region |
|
decreases phosphorylation |
ISO |
20 |
13,972,773 |
14,097,816 |
RGD:6480464 |
CTD |
| G |
Bcr |
breakpoint cluster region |
|
multiple interactions |
ISO |
20 |
13,972,773 |
14,097,816 |
RGD:6480464 |
CTD |
| G |
Bcr |
breakpoint cluster region |
|
decreases activity |
ISO |
20 |
13,972,773 |
14,097,816 |
RGD:6480464 |
CTD |
| G |
Bcr |
breakpoint cluster region |
|
multiple interactions |
ISO |
20 |
13,972,773 |
14,097,816 |
RGD:6480464 |
CTD |
| G |
Bcr |
breakpoint cluster region |
|
decreases phosphorylation |
ISO |
20 |
13,972,773 |
14,097,816 |
RGD:6480464 |
CTD |
| G |
Bid |
BH3 interacting domain death agonist |
|
multiple interactions |
ISO |
4 |
157,296,383 |
157,318,481 |
RGD:6480464 |
CTD |
| G |
Birc2 |
baculoviral IAP repeat-containing 2 |
|
multiple interactions |
ISO |
8 |
4,649,559 |
4,667,733 |
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Birc5 |
baculoviral IAP repeat-containing 5 |
|
decreases response to substance |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
multiple interactions |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Cbl |
Cbl proto-oncogene, E3 ubiquitin protein ligase |
|
multiple interactions |
ISO |
8 |
47,135,357 |
47,211,889 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
multiple interactions |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
multiple interactions |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccna2 |
cyclin A2 |
|
decreases expression |
ISO |
2 |
123,062,752 |
123,069,085 |
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdc25a |
cell division cycle 25A |
|
multiple interactions |
ISO |
8 |
114,237,704 |
114,255,971 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
multiple interactions |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
decreases expression |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
decreases expression |
ISO |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk2 |
cyclin dependent kinase 2 |
|
decreases expression |
ISO |
7 |
2,000,196 |
2,007,682 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
multiple interactions |
ISO |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
ISO |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
|
multiple interactions |
ISO |
9 |
57,309,836 |
57,356,635 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
multiple interactions |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
multiple interactions |
EXP |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Crkl |
v-crk sarcoma virus CT10 oncogene homolog (avian)-like |
|
decreases phosphorylation |
ISO |
11 |
85,520,244 |
85,554,667 |
RGD:6480464 |
CTD |
| G |
Crkl |
v-crk sarcoma virus CT10 oncogene homolog (avian)-like |
|
decreases phosphorylation |
ISO |
11 |
85,520,244 |
85,554,667 |
RGD:6480464 |
CTD |
| G |
Crkl |
v-crk sarcoma virus CT10 oncogene homolog (avian)-like |
|
multiple interactions |
ISO |
11 |
85,520,244 |
85,554,667 |
RGD:6480464 |
CTD |
| G |
Csf1r |
colony stimulating factor 1 receptor |
|
decreases expression |
EXP |
18 |
57,080,324 |
57,107,295 |
RGD:6480464 |
CTD |
| G |
Cul1 |
cullin 1 |
|
multiple interactions |
ISO |
4 |
75,636,914 |
75,705,724 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
multiple interactions |
ISO |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl9 |
chemokine (C-X-C motif) ligand 9 |
|
multiple interactions |
ISO |
14 |
17,284,085 |
17,288,996 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
EXP |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Diablo |
diablo, IAP-binding mitochondrial protein |
|
multiple interactions |
ISO |
12 |
34,196,347 |
34,209,633 |
RGD:6480464 |
CTD |
| G |
Dok1 |
docking protein 1 |
|
decreases phosphorylation |
ISO |
4 |
117,242,746 |
117,245,209 |
RGD:6480464 |
CTD |
| G |
Eif4b |
eukaryotic translation initiation factor 4B |
|
decreases expression |
ISO |
7 |
140,814,663 |
140,836,485 |
RGD:6480464 |
CTD |
| G |
Eif4e |
eukaryotic translation initiation factor 4E |
|
decreases expression |
ISO |
2 |
236,072,748 |
236,104,714 |
RGD:6480464 |
CTD |
| G |
Fadd |
Fas (TNFRSF6)-associated via death domain |
|
multiple interactions |
ISO |
1 |
205,010,363 |
205,012,768 |
RGD:6480464 |
CTD |
| G |
Fbxo16 |
F-box protein 16 |
|
multiple interactions |
ISO |
15 |
44,690,042 |
44,736,309 |
RGD:6480464 |
CTD |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
decreases expression |
ISO |
14 |
82,683,191 |
82,697,229 |
RGD:6480464 |
CTD |
| G |
Gck |
glucokinase |
|
multiple interactions |
ISO |
14 |
86,572,518 |
86,587,723 |
RGD:6480464 |
CTD |
| G |
Gck |
glucokinase |
|
decreases expression |
ISO |
14 |
86,572,518 |
86,587,723 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
increases expression |
ISO |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
multiple interactions |
ISO |
3 |
114,119,316 |
114,138,107 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
decreases expression |
ISO |
3 |
114,119,316 |
114,138,107 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
multiple interactions |
ISO |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock transcription factor 1 |
|
increases expression |
ISO |
7 |
114,524,211 |
114,551,166 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
ISO |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Icam1 |
intercellular adhesion molecule 1 |
|
increases expression |
ISO |
8 |
20,040,177 |
20,051,939 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
multiple interactions |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
|
increases expression |
ISO |
10 |
87,822,429 |
87,834,315 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
decreases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il4r |
interleukin 4 receptor |
|
increases expression |
ISO |
1 |
184,612,903 |
184,637,863 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
multiple interactions |
ISO |
14 |
34,906,043 |
34,984,819 |
RGD:6480464 |
CTD |
| G |
Kit |
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
|
decreases expression |
ISO |
14 |
34,906,043 |
34,984,819 |
RGD:6480464 |
CTD |
| G |
Krt14 |
keratin 14 |
|
increases expression |
ISO |
10 |
89,144,357 |
89,148,415 |
RGD:6480464 |
CTD |
| G |
Krt5 |
keratin 5 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Lck |
lymphocyte-specific protein tyrosine kinase |
|
decreases phosphorylation |
ISO |
5 |
148,707,505 |
148,718,296 |
RGD:6480464 |
CTD |
| G |
LOC100360940 |
diablo-like |
|
multiple interactions |
ISO |
5 |
148,562,065 |
148,563,619 |
RGD:6480464 |
CTD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
decreases response to substance |
ISO |
5 |
16,933,111 |
17,054,564 |
RGD:6480464 |
CTD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
multiple interactions |
ISO |
5 |
16,933,111 |
17,054,564 |
RGD:6480464 |
CTD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
decreases response to substance |
ISO |
5 |
16,933,111 |
17,054,564 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
decreases phosphorylation |
ISO |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk14 |
mitogen activated protein kinase 14 |
|
multiple interactions |
ISO |
20 |
6,939,249 |
7,000,378 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
decreases phosphorylation |
ISO |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mcl1 |
myeloid cell leukemia sequence 1 |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
multiple interactions |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
decreases expression |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
multiple interactions |
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:6480464 |
CTD |
| G |
Nab2 |
Ngfi-A binding protein 2 |
|
increases expression |
ISO |
7 |
67,642,321 |
67,648,713 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
multiple interactions |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
increases phosphorylation |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
ISO |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Odc1 |
ornithine decarboxylase 1 |
|
increases expression |
ISO |
6 |
41,309,211 |
41,315,796 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
decreases expression |
ISO |
7 |
118,244,385 |
118,262,021 |
RGD:6480464 |
CTD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
multiple interactions |
EXP |
7 |
118,244,385 |
118,262,021 |
RGD:6480464 |
CTD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
decreases expression |
ISO |
14 |
35,369,422 |
35,418,126 |
RGD:6480464 |
CTD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
decreases expression |
ISO |
14 |
35,369,422 |
35,418,126 |
RGD:6480464 |
CTD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
multiple interactions |
ISO |
14 |
35,369,422 |
35,418,126 |
RGD:6480464 |
CTD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
decreases expression |
ISO |
14 |
35,369,422 |
35,418,126 |
RGD:6480464 |
CTD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
decreases expression |
EXP |
14 |
35,369,422 |
35,418,126 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
decreases expression |
ISO |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
decreases phosphorylation |
ISO |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
decreases expression |
EXP |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
decreases phosphorylation |
ISO |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
multiple interactions |
EXP |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdhb |
pyruvate dehydrogenase (lipoamide) beta |
|
decreases expression |
ISO |
15 |
18,737,449 |
18,743,391 |
RGD:6480464 |
CTD |
| G |
Pdhb |
pyruvate dehydrogenase (lipoamide) beta |
|
multiple interactions |
ISO |
15 |
18,737,449 |
18,743,391 |
RGD:6480464 |
CTD |
| G |
Pecam1 |
platelet/endothelial cell adhesion molecule 1 |
|
multiple interactions |
ISO |
10 |
96,056,220 |
96,057,232 |
RGD:6480464 |
CTD |
| G |
Pik3r1 |
phosphoinositide-3-kinase, regulatory subunit 1 (alpha) |
|
decreases expression |
ISO |
2 |
32,602,673 |
32,675,350 |
RGD:6480464 |
CTD |
| G |
Potef |
POTE ankyrin domain family, member F |
|
multiple interactions |
EXP |
18 |
24,420,779 |
24,422,284 |
RGD:6480464 |
CTD |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
multiple interactions |
ISO |
4 |
151,492,220 |
151,617,331 |
RGD:6480464 |
CTD |
| G |
Ppp2ca |
protein phosphatase 2, catalytic subunit, alpha isozyme |
|
increases expression |
ISO |
10 |
37,621,256 |
37,641,008 |
RGD:6480464 |
CTD |
| G |
Prkcd |
protein kinase C, delta |
|
multiple interactions |
ISO |
16 |
5,954,218 |
5,975,743 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
multiple interactions |
ISO |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
multiple interactions |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
|
decreases expression |
ISO |
13 |
64,427,288 |
64,432,978 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
multiple interactions |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
multiple interactions |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases methylation |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases phosphorylation |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Ret |
ret proto-oncogene |
|
decreases phosphorylation |
ISO |
4 |
154,448,179 |
154,491,103 |
RGD:6480464 |
CTD |
| G |
Rps6 |
ribosomal protein S6 |
|
multiple interactions |
ISO |
5 |
106,165,612 |
106,168,472 |
RGD:6480464 |
CTD |
| G |
Rps6kb1 |
ribosomal protein S6 kinase, polypeptide 1 |
|
decreases expression |
ISO |
10 |
76,657,024 |
76,698,088 |
RGD:6480464 |
CTD |
| G |
Sohlh1 |
spermatogenesis and oogenesis specific basic helix-loop-helix 1 |
|
decreases expression |
ISO |
3 |
4,015,651 |
4,019,668 |
RGD:6480464 |
CTD |
| G |
Sqstm1 |
sequestosome 1 |
|
increases expression |
EXP |
10 |
35,751,300 |
35,762,630 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
multiple interactions |
ISO |
9 |
46,455,635 |
46,497,560 |
RGD:6480464 |
CTD |
| G |
Stat5a |
signal transducer and activator of transcription 5A |
|
multiple interactions |
ISO |
10 |
89,795,404 |
89,819,732 |
RGD:6480464 |
CTD |
| G |
Tank |
TRAF family member-associated NFKB activator |
|
increases expression |
ISO |
3 |
43,396,247 |
43,475,491 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
multiple interactions |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
decreases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf10b |
tumor necrosis factor receptor superfamily, member 10b |
|
increases expression |
ISO |
15 |
50,138,439 |
50,163,254 |
RGD:6480464 |
CTD |
| G |
Tnfrsf1b |
tumor necrosis factor receptor superfamily, member 1b |
|
multiple interactions |
ISO |
5 |
163,666,541 |
163,697,484 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases secretion |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
ISO |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Wt1 |
Wilms tumor 1 |
|
decreases expression |
ISO |
3 |
90,529,704 |
90,577,280 |
RGD:6480464 |
CTD |
Term paths to the root
|